BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1116 related articles for article (PubMed ID: 19915059)

  • 21. Effector T-cell differentiation during viral and bacterial infections: Role of direct IL-12 signals for cell fate decision of CD8(+) T cells.
    Keppler SJ; Theil K; Vucikuja S; Aichele P
    Eur J Immunol; 2009 Jul; 39(7):1774-83. PubMed ID: 19548244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin-21 activates cytotoxic T lymphocytes and natural killer cells to generate antitumor response in mouse renal cell carcinoma.
    Kumano M; Hara I; Furukawa J; Oniki S; Nagai H; Miyake H; Fujisawa M
    J Urol; 2007 Oct; 178(4 Pt 1):1504-9. PubMed ID: 17707061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+ T cells induce complete regression of advanced ovarian cancers by an interleukin (IL)-2/IL-15 dependent mechanism.
    Yang T; Wall EM; Milne K; Theiss P; Watson P; Nelson BH
    Clin Cancer Res; 2007 Dec; 13(23):7172-80. PubMed ID: 18056198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response.
    Rodrigues L; Nandakumar S; Bonorino C; Rouse BT; Kumaraguru U
    Mol Immunol; 2009 Apr; 46(7):1494-504. PubMed ID: 19233474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
    Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
    Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.
    Kitajima M; Ito T; Tumes DJ; Endo Y; Onodera A; Hashimoto K; Motohashi S; Yamashita M; Nishimura T; Ziegler SF; Nakayama T
    Cancer Res; 2011 Jul; 71(14):4790-8. PubMed ID: 21646476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppressive myeloid-derived suppressor cells can be converted into immunogenic APCs with the help of activated NKT cells: an alternative cell-based antitumor vaccine.
    Ko HJ; Lee JM; Kim YJ; Kim YS; Lee KA; Kang CY
    J Immunol; 2009 Feb; 182(4):1818-28. PubMed ID: 19201833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C-theta is required for NK cell activation and in vivo control of tumor progression.
    Aguiló JI; Garaude J; Pardo J; Villalba M; Anel A
    J Immunol; 2009 Feb; 182(4):1972-81. PubMed ID: 19201850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-15-induced CD8+CD122+ T cells increase antibacterial and anti-tumor immune responses: implications for immune function in aged mice.
    Motegi A; Kinoshita M; Inatsu A; Habu Y; Saitoh D; Seki S
    J Leukoc Biol; 2008 Oct; 84(4):1047-56. PubMed ID: 18653461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basophils can directly present or cross-present antigen to CD8 lymphocytes and alter CD8 T cell differentiation into IL-10-producing phenotypes.
    Kim S; Shen T; Min B
    J Immunol; 2009 Sep; 183(5):3033-9. PubMed ID: 19667092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo expansion of activated naive CD8+ T cells and NK cells driven by complexes of IL-2 and anti-IL-2 monoclonal antibody as novel approach of cancer immunotherapy.
    Tomala J; Chmelova H; Mrkvan T; Rihova B; Kovar M
    J Immunol; 2009 Oct; 183(8):4904-12. PubMed ID: 19801515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination treatment with IL-2 and anti-IL-2 mAbs reduces tumor metastasis via NK cell activation.
    Jin GH; Hirano T; Murakami M
    Int Immunol; 2008 Jun; 20(6):783-9. PubMed ID: 18448458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TLR2 engagement on memory CD8(+) T cells improves their cytokine-mediated proliferation and IFN-gamma secretion in the absence of Ag.
    Cottalorda A; Mercier BC; Mbitikon-Kobo FM; Arpin C; Teoh DY; McMichael A; Marvel J; Bonnefoy-Bérard N
    Eur J Immunol; 2009 Oct; 39(10):2673-81. PubMed ID: 19634192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice.
    Marks-Konczalik J; Dubois S; Losi JM; Sabzevari H; Yamada N; Feigenbaum L; Waldmann TA; Tagaya Y
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11445-50. PubMed ID: 11016962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The immunoregulatory effects of gangliosides involve immune deviation favoring type-2 T cell responses.
    Crespo FA; Sun X; Cripps JG; Fernandez-Botran R
    J Leukoc Biol; 2006 Mar; 79(3):586-95. PubMed ID: 16415169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma.
    Yuan X; Hu J; Belladonna ML; Black KL; Yu JS
    Cancer Res; 2006 Mar; 66(5):2630-8. PubMed ID: 16510582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral 4-1BB signaling negatively regulates NK cell development through IFN-gamma.
    Choi BK; Kim YH; Kim CH; Kim MS; Kim KH; Oh HS; Lee MJ; Lee DK; Vinay DS; Kwon BS
    J Immunol; 2010 Aug; 185(3):1404-11. PubMed ID: 20610645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IL-21: roles in immunopathology and cancer therapy.
    Søndergaard H; Skak K
    Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.